BridgeMD
New treatment option for Parkinson's Disease
Official title A Study Assessing the Effects of Acupuncture in Parkinson's Disease Patients With Chronic Appendicitis
ClinicalTrials.gov ID: NCT06304285
What this study is testing
- What it's testing
- The incidence of PD is high, and when the disease is serious to a certain extent, the effect of drugs to control symptoms decreases, resulting in a significant reduction in the quality of life of patients. Recent studies have found that these PD symptoms are closely related to the intestine.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 70
You may be able to join if
- Patients presenting with bradykinesia, combined with resting tremor and/or myotonia.
- Appendix CT suggested chronic appendicitis evaluated by two experienced experts.
- All people and their guardians give informed consent to the content of this study and sign informed consent.
- Normal coagulation function.
- If the patient had taken oral anti-PD drugs, it had been stable for at least 2 weeks at enrollment.
You likely can't join if
- Treatment with dopamine blockers or dopamine depleters in doses and time courses consistent with drug-induced parkinsonism.
- Neuroimaging examination of presynaptic dopaminergic system function was normal.
- Patients who had suffered severe brain trauma or underwent complex craniotomy within 5 years prior to enrollment.
- Cognitive disorders that are not on the Parkinson's spectrum, such as Alzheimer's disease, frontotemporal dementia, and Niemann-Pick disease, have...
- People diagnosed with severe neuropsychiatric disorders (epilepsy, bipolar disorder, major depressive episode, etc.) according to DSM-V.
- Complicated with serious systemic diseases, disorders of consciousness, stroke, serious coronary heart disease, diabetes, liver and kidney diseases...
See the full eligibility criteria
- Patients presenting with bradykinesia, combined with resting tremor and/or myotonia.
- Appendix CT suggested chronic appendicitis evaluated by two experienced experts.
- All people and their guardians give informed consent to the content of this study and sign informed consent.
- Normal coagulation function.
- If the patient had taken oral anti-PD drugs, it had been stable for at least 2 weeks at enrollment.
- Treatment with dopamine blockers or dopamine depleters in doses and time courses consistent with drug-induced parkinsonism.
- Neuroimaging examination of presynaptic dopaminergic system function was normal.
- Patients who had suffered severe brain trauma or underwent complex craniotomy within 5 years prior to enrollment.
- Cognitive disorders that are not on the Parkinson's spectrum, such as Alzheimer's disease, frontotemporal dementia, and Niemann-Pick disease, have been diagnosed.
- People diagnosed with severe neuropsychiatric disorders (epilepsy, bipolar disorder, major depressive episode, etc.) according to DSM-V.
- Complicated with serious systemic diseases, disorders of consciousness, stroke, serious coronary heart disease, diabetes, liver and kidney diseases, and serious visual and hearing disorders.
- Patients with severe organic or functional dysphagia;Those who were deemed by the researcher to be unable to complete the visit and auxiliary examination as required by the study protocol.
The study team makes the final eligibility decision.
Where it's taking place
- Hefei, Anhui, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hefei, Anhui, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.